Dropless vs. Standard Drops Contralateral Eye Study
Public ClinicalTrials.gov record NCT02515045. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparison of Dropless Prophylaxis After Routine Phacoemulsification to Standard Drops Regimen
Study identification
- NCT ID
- NCT02515045
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Carolina Eyecare Physicians, LLC
- Other
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Interventions
- TriMoxiVanc Drug
- Moxifloxacin HCl 0.5% Drug
- Ilevro Drug
- Prednisolone acetate 1% Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2014
- Primary completion
- Feb 29, 2016
- Completion
- Feb 29, 2016
- Last update posted
- Feb 22, 2018
2015 – 2016
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Minnesota Eye Consultants, P.A. | Bloomington | Minnesota | 55431 | — |
| Associated Eye Care | Stillwater | Minnesota | 55082 | — |
| Ophthalmic Consultants of Long Island | Garden City | New York | 11530 | — |
| Carolina Eyecare Physicians, LLC | Mt. Pleasant | South Carolina | 29464 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02515045, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2018 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02515045 live on ClinicalTrials.gov.